Salivary psoriasin (S100A7) correlates with diffusion capacity of carbon monoxide in a large cohort of systemic sclerosis patients

Journal of Translational Medicine

Volumn 14, Issue 1, 2016, Pages

  Giusti, Laura ^a   Sernissi, Francesca ^a   Donadio, Elena ^a   Ciregia, Federica ^a   Giacomelli, Camillo ^a   Giannaccini, Gino ^a   Mazzoni, Maria Rosa ^a   Lucacchini, Antonio ^a   Bazzichi, Laura ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Biomarker; Diffusion capacity of carbon monoxide (DLCO); Psoriasin; S100A7; Systemic sclerosis (SSc); Whole saliva

Indexed keywords

PSORIASIN; CARBON MONOXIDE; PROTEIN S 100; S100A7 PROTEIN, HUMAN;

ADULT; ARTICLE; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; DIFFUSION CAPACITY OF CARBON MONOXIDE; ELISA KIT; FEMALE; HUMAN; LUNG DIFFUSION CAPACITY; LUNG FIBROSIS; MAJOR CLINICAL STUDY; MALE; NON INVASIVE MEASUREMENT; PREDICTIVE VALUE; RAYNAUD PHENOMENON; RECEIVER OPERATING CHARACTERISTIC; SALIVA LEVEL; SENSITIVITY AND SPECIFICITY; SYSTEMIC SCLEROSIS; CASE CONTROL STUDY; COHORT ANALYSIS; DIFFUSION; METABOLISM; MIDDLE AGED; SALIVA;

CARBON MONOXIDE; CASE-CONTROL STUDIES; COHORT STUDIES; DIFFUSION; FEMALE; HUMANS; MALE; MIDDLE AGED; ROC CURVE; S100 PROTEINS; SALIVA; SCLERODERMA, SYSTEMIC;

EID: 84986295284     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/s12967-016-1023-5     Document Type: Article

References (18)

1. Donato R, Cannon BR, Sorci G, Riuzzi F, Hsu K, Weber DJ, Geczy CL. Function of S100 proteins. Curr Mol Med. 2013;13:24-57.
2. Heizmann CW, Fritz G, Schäfer BW. S100 proteins: structure, functions and pathology. Front Biosci. 2002;7:d1356-68.
3. Madsen P, Rasmussen HH, Leffers H, Honoré B, Celis JE. Molecular cloning, occurrence, and expression of a novel partially secreted protein "psoriasin" that is highly up-regulated in psoriatic skin. J Invest Dermatol. 1991;97:701-12.
4. Wolf R, Ruzicka T, Yuspa SH. Novel S100A7 (psoriasin)/S100A15 (koebnerisin) subfamily: highly homologous but distinct in regulation and function. Amino Acids. 2011;41:789-96.
5. Hegyi Z, Zwicker S, Bureik D, Peric M, Koglin S, Batycka-Baran A, Prinz JC, Ruzicka T, Schauber J, Wolf R. Vitamin D analog calcipotriol suppresses the Th17 cytokine-induced proinflammatory S100 "alarmins" psoriasin (S100A7) and koebnerisin (S100A15) in psoriasis. J Invest Dermatol. 2012;132:1416-24.
6. Olewicz-Gawlik A, Danczak-Pazdrowska A, Kuznar-Kaminska B, Gornowicz-Porowska J, Katulska K, Trzybulska D, Batura-Gabryel H, Silny W, Poplawski D, Hrycaj P. Interleukin-17 and interleukin-23: importance in the pathogenesis of lung impairment in patients with systemic sclerosis. Int J Rheum Dis. 2014;17:664-70.
7. Lakota K, Carns M, Podlusky S, Mrak-Poljsak K, Hinchcliff M, Lee J, Tomsic M, Sodin-Semrl S, Varga J. Serum amyloid A is a marker for pulmonary involvement in systemic sclerosis. PLoS ONE. 2015;10:e0110820.
8. Baldini C, Giusti L, Bazzichi L, Ciregia F, Giannaccini G, Giacomelli C, Doveri M, Del Rosso M, Bombardieri S, Lucacchini A. Association of psoriasin (S100A7) with clinical manifestations of systemic sclerosis: is its presence in whole saliva a potential predictor of pulmonary involvement? J Rheumatol. 2008;35:1820-4.
9. van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, Matucci-Cerinic M, Naden RP, Medsger TA Jr, Carreira PE, Riemekasten G, Clements PJ, Denton CP, Distler O, Allanore Y, Furst DE, Gabrielli A, Mayes MD, van Laar JM, Seibold JR, Czirjak L, Steen VD, Inanc M, Kowal-Bielecka O, Müller-Ladner U, Valentini G, Veale DJ, Vonk MC, Walker UA, Chung L, Collier DH, Csuka ME, Fessler BJ, Guiducci S, Herrick A, Hsu VM, Jimenez S, Kahaleh B, Merkel PA, Sierakowski S, Silver RM, Simms RW, Varga J, Pope JE. 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative. Arthritis Rheum. 2013;65:2737-47.
10. Giusti L, Baldini C, Bazzichi L, Ciregia F, Tonazzini I, Mascia G, Giannaccini G, Bombardieri S, Lucacchini A. Proteome analysis of whole saliva: a new tool for rheumatic diseases-the example of Sjögren's syndrome. Proteomics. 2007;7:1634-43.
11. Suliman YA, Dobrota R, Huscher D, Nguyen-Kim TD, Maurer B, Jordan S, Speich R, Frauenfelder T, Distler O. Brief report: pulmonary function tests: high rate of false-negative results in the early detection and screening of scleroderma-related interstitial lung disease. Arthritis Rheumatol. 2015;67:3256-61.
12. Giusti L, Bazzichi L, Baldini C, Ciregia F, Mascia G, Giannaccini G, Del Rosso M, Bombardieri S, Lucacchini A. Specific proteins identified in whole saliva from patients with diffuse systemic sclerosis. J Rheumatol. 2007;34:2063-9.
13. Jia J, Duan Q, Guo J, Zheng Y. Psoriasin, a multifunctional player in different diseases. Curr Protein Pept Sci. 2014;15:836-42.
14. + regulatory T cells with clinical parameters in patients with systemic sclerosis. Chin Med J (Engl). 2014;127:3557-61.
15. Amado FM, Ferreira RP, Vitorino R. One decade of salivary proteomics: current approaches and outstanding challenges. Clin Biochem. 2013;46:506-17.
16. Ciregia F, Giusti L, Da Valle Y, Donadio E, Consensi A, Giacomelli C, Sernissi F, Scarpellini P, Maggi F, Lucacchini A, Bazzichi L. A multidisciplinary approach to study a couple of monozygotic twins discordant for the chronic fatigue syndrome: a focus on potential salivary biomarkers. J Transl Med. 2013;11:243.
17. Baldini C, Giusti L, Ciregia F, Da Valle Y, Giacomelli C, Donadio E, Ferro F, Galimberti S, Donati V, Bazzichi L, Bombardieri S, Lucacchini A. Correspondence between salivary proteomic pattern and clinical course in primary Sjögren syndrome and non-Hodgkin's lymphoma: a case report. J Transl Med. 2011;9:188.
18. Bazzichi L, Ciregia F, Giusti L, Baldini C, Giannaccini G, Giacomelli C, Sernissi F, Bombardieri S, Lucacchini A. Detection of potential markers of primary fibromyalgia syndrome in human saliva. Proteom Clin Appl. 2009;3:1296-304.